| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.4 | 0.09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |